Death due to COVID‐19 in a patient with diabetes, epilepsy, and gout comorbidities

Clinical Case Reports

Kaveh Momenzadeh¹  Pooya Farhangnia²  Amir Reza Safdarian³  Farima Kahe⁴  Nima Rezaei⁵ 

[1] Center for Advanced Orthopaedic Studies Beth Israel Deaconess Medical Center Harvard Medical School Boston MA USA;Department of Immunology Iran University of Medical Sciences Tehran Iran;Department of Pathology Alborz University of Medical Sciences Alborz Iran;Division of Cardiovascular Medicine Beth Israel Deaconess Medical Center Harvard Medical School Boston MA USA;Research Center for Immunodeficiencies Tehran University of Medical Sciences Tehran Iran;

关键词: comorbidities;    coronavirus;    COVID‐19;    diabetes;    epilepsy;   

DOI  :  10.1002/ccr3.3557

来源: DOAJ

【 摘 要 】

Abstract There is evidence of increased incidence, rapid progression, and poor prognosis of COVID‐19 in patients with underlying comorbidities such as diabetes and epilepsy. Developing effective treatment regimens for COVID‐19 patients with multiple comorbidities is crucial, as patients' past medical history is an essential contributor to possible organ injuries in COVID‐19 patients. Herein, we report a confirmed case of COVID‐19 patient with a history of multiple underlying diseases, including diabetes, epilepsy, and gout. The patient developed multiple organ failure and died a week after intensive care unit (ICU) admission. Multiple organ failure is the most common cause of death in COVID‐19 patients.

【 授权许可】

Unknown